SCHEMBL5804452

SCHEMBL5804452

C=CCCNC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1142734 0.86
SCHEMBL27388605 0.84 ALDH1A1 (0.47)
Urea SCHEMBL235649 0.79 ALDH1A1 (0.50)
SCHEMBL9242577 0.79 ALDH1A1 (0.38)
SCHEMBL8316401 0.79 TDP1 (0.37)
SCHEMBL22856384 0.79 EPHX1 (0.37)
Formaldehyde SCHEMBL7061736 0.78 TDP1 (0.33)
Urea SCHEMBL11541326 0.78 ALDH1A1 (0.33)
SCHEMBL14526173 0.77
SCHEMBL5312005 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823420-B1 Substituted vinylurea derivatives and their use as ACAT inhibitors SS PHARMACEUTICAL CO (JP) 2001-10-24 EP claimed
US-5866609-A PROPHYLACTIC AND THERAPEUTIC AGENTS FOR ARTERIOSCLEROSIS. SS PHARMACEUTICAL CO., LTD. (JP) 1999-02-02 US claimed
EP-0823420-A2 Substituted vinylurea derivatives and their use as ACAT inhibitors SS PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP claimed
WO-2023016488-A1 MICROTUBULE INHIBITOR-BASED ANTIBODY-DRUG CONJUGATE 昆山新蕴达生物科技有限公司 2023-02-16 WO disclosed
WO-2023278592-A1 RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT DUKE UNIVERSITY (US) 2023-01-05 WO disclosed
WO-2022115451-A1 MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE NOVARTIS AG (CH) 2022-06-02 WO disclosed
WO-2022115477-A1 BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2022-06-02 WO disclosed
WO-2022078462-A1 NOVEL GLUTAMINE ANALOGS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2022-04-21 WO disclosed
US-11180533-B2 Process for the preparation of Cetrorelix acetate BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (IN) 2021-11-23 US disclosed
WO-2021209007-A1 ANTIBODY-DRUG CONJUGATE SHENZHEN ENDURING BIOTECH, LTD. (CN) 2021-10-21 WO disclosed
EP-3464280-B1 SILVESTROL ANTIBODY-DRUG CONJUGATES AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2021-10-06 EP disclosed
EP-2845866-B1 Antibodies and immunoconjugates and uses therefor GENENTECH INC (US) 2017-05-03 EP disclosed
EP-2956173-B1 TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE BRISTOL MYERS SQUIBB CO (US) 2017-03-29 EP disclosed
WO-2017009255-A1 COMPOSITIONS COMPRISING ANTIBODY-DUOCARMYCIN DRUG CONJUGATES SYNTHON BIOPHARMACEUTICALS B.V. (NL) 2017-01-19 WO disclosed
WO-2006069096-A1 SILANOL DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2006-06-29 WO disclosed
EP-0823420-B1 Substituted vinylurea derivatives and their use as ACAT inhibitors SS PHARMACEUTICAL CO (JP) 2001-10-24 EP disclosed
US-5866609-A PROPHYLACTIC AND THERAPEUTIC AGENTS FOR ARTERIOSCLEROSIS. SS PHARMACEUTICAL CO., LTD. (JP) 1999-02-02 US disclosed
EP-0823420-A2 Substituted vinylurea derivatives and their use as ACAT inhibitors SS PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed
US-4260552-A INSECTICIDES, HERBICIDES UNIROYAL, INC. (US) 1981-04-07 US disclosed
US-4160846-A Method for controlling insects with tetrasubstituted organotin compounds UNIROYAL, INC. (US) 1979-07-10 US disclosed